Pharmaceutical Manufacturing News and Research

RSS

Prednisone tablets less variable than marketed drugs

The U.S. Pharmacopeial (USP) Convention has announced results of a study comparing the dissolution variability of USP Prednisone Lot P Reference Standard tablets to two marketed drugs.

2 Apr 2008

First comprehensive database of microorganisms known to live in the mouth

Scientists know more today than ever before about the microbes that inhabit our mouths.

26 Mar 2008

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting

Eisai Corporation of North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.

4 Mar 2008

Innovative drug production project secures funding from Technology Strategy Board

PolyTherics, a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, has announced that it has secured funding from the Technology Strategy Board.

29 Nov 2007

Is the U.S. ready for bird flu? No

A new report from the White House has revealed that the United States remains unprepared for a possible bird flu pandemic.

19 Jul 2007

Engineered minichromosomes for medically useful proteins and metabolites

A team of scientists at the University of Missouri-Columbia has discovered a way to create engineered minichromosomes in maize and attach genes to those minichromosomes.

16 May 2007

FDA says beware of glycerin imported from China

The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.

7 May 2007

Abbott opens biotech facility in Puerto Rico

"This new facility is a key milestone for Abbott as we move to focus our resources and future growth on biologic and potent-drug manufacturing," said Lawrence Kraus, vice president of manufacturing, global pharmaceutical operations, Abbott.

11 Apr 2007

Thailand threatens big pharma companies

Thailand's minister for health has reportedly threatened to override international patents on even more drugs if the big pharmaceutical manufacturers do not significantly cut their prices.

19 Feb 2007

Cell therapy for Parkinson's

Parkinson's disease is one of the commonest afflictions caused by damage to the nerve cells of the brain. Patients suffer from muscular tremors and rigidity, and their movements are severely impaired.

8 Jan 2007

Thailand's antiretroviral drug provision program should serve as a model for other poorer countries

Thailand's HIV/AIDS prevention and treatment programs should serve as a model for other countries with limited resources to fight the disease, according to a World Bank report released on Wednesday at the XVI International AIDS Conference in Toronto, Reuters UK reports.

17 Aug 2006

FDA warns pharmacies to stop mass-producing unapproved inhalation drugs

FDA has warned three firms, RoTech Healthcare, Inc., CCS Medical, and Reliant Pharmacy Services, to stop manufacturing and distributing thousands of doses of compounded, unapproved inhalation drugs nation-wide.

10 Aug 2006

Cardinal Health to manufacture Tamiflu for Roche

Cardinal Health, the leading provider of products and services supporting the health-care industry, has announced that it has signed agreements to manufacture and package Tamiflu for Roche to help meet current and future demand for the influenza medicine.

10 Jul 2006

University of Calgary researchers develop bioreactor procedures to grow pancreatic cells in their laboratory

Freedom from insulin injections and the myriad of health problems related to type 1 diabetes is closer to becoming reality, thanks to University of Calgary researchers who are developing the first bioreactor procedures to grow pancreatic cells in their laboratory.

21 Mar 2006

Drug discovery companies turn to low-cost Asian countries to evade stringent regulations

The Indian and Chinese drug discovery outsourcing market is riding a crest with companies from outside Asia increasingly seeking to outsource drug discovery to these countries for greater cost savings. Other major factors driving this shift to Indian and Chinese companies are the better access to expertise, productivity gains, process improvements, variable costs, avoidance of capital outlays and opportunities for companies to focus on specific niches.

16 Jan 2006

Putting things in prespective - help the world's children to fight bird flu

Amid the escalating panic in Europe centered around attempts to halt the spread among the bird population of bird flu, a senior health expert has said that swift action against age-old child killers such as diarrhea and pneumonia could help the world get ready to combat a bird flu pandemic.

19 Oct 2005

Anti-cancer antibodies produced in chickens

A team of researchers have produced the first fully functional, human sequence monoclonal antibodies (mAbs) in chickens.

29 Aug 2005

New chemical reaction that could greatly accelerate pharmaceutical production

University of Toronto researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.

19 Apr 2005

Indian production of cheap generic drugs could be banned

To ensure India meets World Trade Organisation (WTO) rules on the production of drugs, the Indian Parliament has approved legislation by the parliament's lower house, to ban domestic firms from manufacturing low-cost generic copies of patented drugs.

22 Mar 2005

Batches of the drugs Paxil and Avandamet seized by federal officials

Batches of the drugs Paxil CR and Avandamet United States, were seized by marshals at manufacturing and distribution plants in Tennessee and Puerto Rico after federal officials said the manufacturer failed to correct violations of production safety standards.

5 Mar 2005